Comprehensive Identification of FXR1 Targets Using pSILAC-BONCAT Proteomics
Comprehensive Identification of FXR1 Targets Using pSILAC-BONCAT Proteomics
批准号:
9241667
负责人:
Viswanathan Palanisamy
金额:
$22.43万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-01-01 至 2018-12-31
关键词:
AffectAmino AcidsApoptosisArchitectureBioinformaticsBiologicalBiological AssayBiological ProcessBypassCDKN1A geneCell AgingCell Culture TechniquesCell Cycle ArrestCell LineCellsChemistryClinicDataDevelopmentDiseaseDissectionEmbryoEukaryotic CellEventFMR1FXR1 geneFamilyFibroblastsFoundationsFragile X SyndromeG1 PhaseGene ExpressionGene Expression AlterationGene Expression ProfileGenesGeneticGenetic TranscriptionGenetic TranslationGoalsHead and Neck CancerHumanImmunoprecipitationLaboratoriesMalignant - descriptorMalignant Epithelial CellMalignant NeoplasmsMass Spectrum AnalysisMediatingMessenger RNAMolecularMolecular ProfilingMouth CarcinomaMusNon-Small-Cell Lung CarcinomaOntologyOralPathway interactionsPatternPhenotypePhysiologic pulsePlayPolyribosomesPost-Transcriptional RegulationPredispositionPrevalenceProteinsProteomeProteomicsPublishingRNARNA ProcessingRNA-Binding ProteinsRecruitment ActivityRegulationRegulator GenesReportingResearchRoleStable Isotope LabelingStimulusStressSurvival RateSystems BiologyTP53 geneTelomerase RNA ComponentTestingTranscription ProcessTranslatingTranslationsTumor TissueValidationWestern Blottingaggressive therapybasecancer cellcarcinogenesisconventional therapyexperiencegenetic signaturegenome-widehead and neck cancer patienthigh throughput analysiskeratinocyteknock-downloss of functionmRNA DecaymRNA Stabilitymalignant mouth neoplasmmouth squamous cell carcinomamutantneoplastic cellnew therapeutic targetnovel markeroverexpressionpreventprotein expressionscreeningsenescencesmall hairpin RNAtargeted treatmenttherapeutic targettherapy resistanttumortumor heterogeneitytumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The purpose of this project is to determine the post-transcriptional regulation that changes the
progression of oral cancer via the RNA-binding protein FXR1 and its mRNA translational control that govern
cellular senescence. FXR1 was considered as a critical regulator of gene expression in most of the eukaryotic
cells by controlling mRNA stability and translation. Thus, the main goal of this project is to understand the
molecular mechanisms of FXR1-mediated mRNA translation and their implications in oral squamous cell
carcinoma (OSCC) cellular senescence. Cellular senescence is an important mechanism for preventing the
proliferation of potential cancer cells. Hence, underpinning the mechanistic aspects of cellular machinery by
dissection the protein expression profiles provides novel biomarkers and/or therapeutic targets. Our laboratory
has extensive experience in studying RNA-binding proteins and high throughput analysis of protein expression
by pulsed-stable isotope labeling with amino acids in cell culture (pSILAC). We have developed a genome-
wide shRNA screen of RBPs to test the cellular senescence in oral cancer cells. By studying oral cancer cells
for cellular senescence, we have discovered FXR1 is overexpressed and depletion of FXR1 induces cellular
senescence. Interestingly, FXR1 is a major player to control the expression of protein at the translational level
that could mediate cellular senescence. Hence, we plan to systematically study the phenotypic changes of
cellular senescence in oral cancer cells by understanding the expression of proteins that are controlled by
FXR1. Thus, our central hypothesis is to understand how overexpression of FXR1 in oral cancer cells alter the
protein expression by modulating RNA processing machinery to control cellular senescence. We propose the
following specific aims to test this hypothesis: 1) to determine the critical role of FXR1 in bypassing OSCC
senescence. We will test if the gain- and loss-of-function of FXR1 affects senescence in OSCC cells through
various cell biological senescence assays, 2) to determine the consequence of FXR1 dysregulation on the
cellular proteome. The protein targets of FXR1 will be identified using pulsed-Stable Isotope Labeling of Cells
in cultured OSCC cells with click-chemistry Bioorthogonal Noncanonical Amino Acid Tagging (pSILAC-
BONCAT) and Mass Spectrometry.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting of RNA-binding protein FXR1 in HNSCC
-
批准号:10571379
-
项目类别:
-
资助金额:$41.94万
-
财政年份:2023
-
负责人:Viswanathan Palanisamy
-
依托单位:
Mechanisms Of RNA-Binding Protein-Mediated Apoptosis In Oral Mucositis
-
批准号:9237260
-
项目类别:
-
资助金额:$44.95万
-
财政年份:2013
-
负责人:Viswanathan Palanisamy
-
依托单位:
Mechanisms Of RNA-Binding Protein-Mediated Apoptosis In Oral Mucositis
-
批准号:8657030
-
项目类别:
-
资助金额:$35.88万
-
财政年份:2013
-
负责人:Viswanathan Palanisamy
-
依托单位:
Mechanisms Of RNA-Binding Protein-Mediated Apoptosis In Oral Mucositis
-
批准号:8993725
-
项目类别:
-
资助金额:$2.53万
-
财政年份:2013
-
负责人:Viswanathan Palanisamy
-
依托单位:
Mechanisms Of RNA-Binding Protein-Mediated Apoptosis In Oral Mucositis
-
批准号:8503886
-
项目类别:
-
资助金额:$32.87万
-
财政年份:2013
-
负责人:Viswanathan Palanisamy
-
依托单位:
MOLECULAR MECHANISMS OF MRNA STABILITY IN HUMAN SALIVA
-
批准号:8360486
-
项目类别:
-
资助金额:$21.1万
-
财政年份:2011
-
负责人:Viswanathan Palanisamy
-
依托单位:
MOLECULAR MECHANISMS OF MRNA STABILITY IN HUMAN SALIVA
-
批准号:8167773
-
项目类别:
-
资助金额:$21.31万
-
财政年份:2010
-
负责人:Viswanathan Palanisamy
-
依托单位:
Regulation of mRNA Stability in Human Saliva
-
批准号:7769275
-
项目类别:
-
资助金额:$24.9万
-
财政年份:2009
-
负责人:Viswanathan Palanisamy
-
依托单位:
Regulation of mRNA Stability in Human Saliva
-
批准号:8044130
-
项目类别:
-
资助金额:$23.69万
-
财政年份:2009
-
负责人:Viswanathan Palanisamy
-
依托单位:
Regulation of mRNA Stability in Human Saliva
-
批准号:7879998
-
项目类别:
-
资助金额:$24.65万
-
财政年份:2009
-
负责人:Viswanathan Palanisamy
-
依托单位:
Regulation of mRNA Stability in Human Saliva
-
批准号:7318300
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2007
-
负责人:Viswanathan Palanisamy
-
依托单位:
Regulation of mRNA Stability in Human Saliva
-
批准号:7460825
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2007
-
负责人:Viswanathan Palanisamy
-
依托单位:
海外基金